Morales, M. A.
Piacenti, M.
Nesti, M.
Solarino, G.
Pieragnoli, P.
Zucchelli, G.
Del Ry, S.
Cabiati, M.
Vozzi, F. http://orcid.org/0000-0001-5457-2328
Funding for this research was provided by:
regione toscana
Article History
Received: 15 June 2021
Accepted: 23 September 2021
First Online: 13 October 2021
Declarations
:
: The BrAID study was reviewed and approved by the Comitato Etico Area Vasta Nord Ovest (CEAVNO) (version 1–08/09/2020) in November 2020 (Approval Number: 18542 – 05/11/2020). The study will be carried out in accordance with recognized ethical principles and good clinical practice for clinical trials. Written informed consent will be obtained from all patients (see Supplementary files A-E for the consent forms) by specialists of clinical centers involved in the trial. It will ensure the protection of individuals as recommended in the Oviedo Convention and the Declaration of Helsinki. BrAID trial is retrospectively registered on ClinicalTrial.gov. Trial registration: Clinical Trial.gov, NCT04641585. Registered 17 November 2020,ExternalRef removed
: Not applicable.
: The authors declare that they have no competing interests.